AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $37,917 | -12.6% | 1,532 | 0.0% | 0.00% | -25.0% |
Q2 2023 | $43,386 | +23.5% | 1,532 | +0.1% | 0.00% | +33.3% |
Q1 2023 | $35,144 | -18.3% | 1,530 | -0.1% | 0.00% | -25.0% |
Q4 2022 | $43,019 | +0.0% | 1,532 | +0.1% | 0.00% | 0.0% |
Q3 2022 | $43,000 | +26.5% | 1,530 | 0.0% | 0.00% | +33.3% |
Q2 2022 | $34,000 | -24.4% | 1,530 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $45,000 | -10.0% | 1,530 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $50,000 | -29.6% | 1,530 | 0.0% | 0.00% | -40.0% |
Q3 2021 | $71,000 | -15.5% | 1,530 | 0.0% | 0.01% | -16.7% |
Q2 2021 | $84,000 | +6.3% | 1,530 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $79,000 | +19.7% | 1,530 | 0.0% | 0.01% | +20.0% |
Q4 2020 | $66,000 | +112.9% | 1,530 | +73.9% | 0.01% | +66.7% |
Q3 2020 | $31,000 | -34.0% | 880 | 0.0% | 0.00% | -25.0% |
Q2 2020 | $47,000 | +51.6% | 880 | 0.0% | 0.00% | +33.3% |
Q1 2020 | $31,000 | – | 880 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |